🇳🇱 Netherlands Country × Condition
breast cancer Clinical Trials in Netherlands
Active clinical trials for breast cancer with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 2, Phase 3 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇳🇱 Netherlands
Active Trials in Netherlands (4)
NCT06335069 Phase 2
Recruiting
18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.
Enrollment
20 pts
Country
🇳🇱 Netherlands
Maastricht University Medical Cente...
View Trial → NCT06106529 Phase 3
Recruiting
REDucing Hot FLASHes in Women Using Endocrine Therapy.
Enrollment
260 pts
Country
🇳🇱 Netherlands
Reinier de Graaf Groep
View Trial → NCT07703033
Recruiting
Multicenter Cardiac Decision Impact Study in People With Breast Cancer
Enrollment
1,000 pts
Country
🇳🇱 Netherlands
UMC Utrecht
View Trial → NCT05062707
Recruiting
Early Ageing During Therapy in AYA Cancer Patients
Enrollment
120 pts
Country
🇳🇱 Netherlands
University Medical Center Groningen
View Trial → Frequently Asked Questions
How many breast cancer clinical trials are active in Netherlands?
There are currently 4 active clinical trials for breast cancer with sites in Netherlands, of which 4 are actively recruiting patients.
How can I join a breast cancer clinical trial in Netherlands?
To join a breast cancer clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are breast cancer trials in Netherlands?
Active breast cancer trials in Netherlands span Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology